By admin 
The scale of the impending crisis was brought into sharp focus by a recent report from Aon, the global professional services and management consulting firm. According to Aon’s latest actuarial projections, employer-sponsored health care costs in the United States are expected to surge by 9.5% in 2027. This follows several years of mid-to-high single-digit increases, creating a compounding effect that is rapidly outstripping tax revenue growth and general inflation. For public sector employers, who often operate on fixed budgets and are legally bound to provide robust benefits through collective bargaining agreements, this nearly double-digit jump is more than a mere line-item adjustment—it is a budgetary catastrophe.
In Dauphin County, Pennsylvania, the human and political cost of this trend is already visible. Justin Douglas, a county commissioner, recently oversaw a property tax increase specifically designed to bridge the widening gap created by rising health care expenditures. For Douglas and his colleagues, the decision was agonizing. To cover the health care costs of the county’s workforce—those who manage the jails, maintain the roads, and provide social services—the county had to reach deeper into the pockets of its residents. This dynamic creates a vicious cycle: as health care costs rise, the "social determinants of health" for the broader community may actually decline as public funds are diverted from infrastructure, education, and community development into the coffers of health systems and pharmaceutical manufacturers.
The Aon report’s findings are particularly striking given the advice offered by the firm’s leadership. Aon’s chief actuary noted in a press release that "employers will need better data and deeper insights to understand where costs are rising." While logically sound, this advice rings hollow to many industry observers and benefits managers. Aon, along with other "Big Three" consultants like Mercer and Willis Towers Watson, has faced intense scrutiny for its role in the very opacity it now decries. In recent years, legal challenges and investigative reports have highlighted instances where these consulting giants have effectively blocked employers from accessing their own claims data, often due to restrictive contracts with Pharmacy Benefit Managers (PBMs) like Express Scripts.
This paradox—where the entities tasked with managing costs are the ones potentially obscuring the data needed to do so—is at the heart of the "vise" currently crushing public sector plans. Without granular data on where every dollar is going, plan sponsors are essentially flying blind. They cannot see if they are being overcharged for specialty drugs, if their PBM is pocketing rebates that should belong to the taxpayer, or if certain hospital systems are leveraging their local monopolies to demand uncompetitive rates.
The primary drivers of the 2027 cost spike are multifaceted, but none is more prominent than the explosion of GLP-1 medications. Drugs like Ozempic, Wegovy, and Mounjaro, originally designed for diabetes but now widely used for weight loss, have created an unprecedented actuarial challenge. The demand for these drugs is massive, and their price tags—often exceeding $1,000 per patient per month—are staggering. For a public sector employer with thousands of employees and dependents, even a 5% uptake rate for GLP-1s can add millions of dollars in annual spending. Unlike a private corporation that might be able to offset these costs by raising prices on its products or reducing its profit margin, a county or school district has only two options: cut benefits or raise taxes.
Beyond the "weight-loss drug" phenomenon, the structural consolidation of the American healthcare system continues to exert upward pressure on costs. As large hospital systems acquire independent physician practices and smaller community hospitals, they gain immense bargaining power over insurers and self-insured employers. In many regions, a single health system now controls the vast majority of specialty care and inpatient services, allowing them to dictate prices that have little correlation with the quality or actual cost of care provided. Public sector plans, which often have high "richness" in their benefit designs to attract and retain talent in a competitive labor market, are particularly vulnerable to these price hikes.
Furthermore, the "shadow" economy of health care—the complex web of rebates, administrative fees, and spread pricing utilized by PBMs—remains a significant drain on public resources. While PBMs argue that they use their scale to negotiate lower prices from drugmakers, a growing body of evidence suggests that much of those savings never reach the plan sponsor. Instead, they are often absorbed into the complex financial structures of the PBMs themselves, which are now almost entirely owned by or affiliated with major health insurance companies like CVS Health (Aetna), UnitedHealth Group (Optum), and Cigna (Express Scripts).
The legal landscape is also shifting, adding a new layer of pressure on public sector officials. Under the Consolidated Appropriations Act of 2021 (CAA), employers and plan sponsors are now explicitly designated as fiduciaries for their health plans. This means that individuals like Justin Douglas and other local government leaders are legally responsible for ensuring that the health plan’s assets are spent prudently and that the fees paid to service providers are "reasonable." This is a high bar to clear when those same service providers refuse to share the data necessary to audit those fees. We are beginning to see a wave of litigation where employees are suing their employers for failing to manage health plan costs effectively, alleging that the "fiduciary" failed in their duty by allowing PBMs or brokers to overcharge the plan.
For the public sector, the political ramifications are as severe as the financial ones. When a school board is forced to choose between hiring five new teachers or covering the 10% increase in health insurance premiums for the existing staff, the community loses. When a city delays road repairs to ensure its police officers have access to the latest specialty medications, the infrastructure of the city suffers. This is the "vise" in action: a tightening grip that leaves no room for error and offers no easy way out.
Expert perspectives suggest that the only way to break the vise is through radical transparency and structural reform. Some forward-thinking public sector plans are moving toward "reference-based pricing," where the plan pays a set percentage above Medicare rates for services, regardless of the hospital’s "sticker price." Others are exploring direct contracting with local providers, bypassing the traditional insurance networks and the "middleman" fees associated with them. However, these strategies require a high degree of administrative sophistication and the political will to withstand the inevitable backlash from powerful local health systems.
As we look toward 2027, the warning from Aon serves as a harbinger of a broader reckoning. The traditional model of employer-sponsored insurance, particularly in the public sector, is becoming unsustainable. The 9.5% projected increase is not just a statistic; it is a signal that the current system of opaque pricing, misaligned incentives, and unchecked consolidation is reaching its logical conclusion.
To survive this crunch, public sector leaders must move beyond the "advice" of their traditional brokers and demand the "deeper insights" that have been withheld for too long. They must treat health care spending not as an uncontrollable "act of God," but as a manageable business expense that requires the same level of scrutiny as any other multi-million dollar government contract. Without this shift in approach, the vise will only continue to tighten, leaving taxpayers and public servants alike to pay the price for a system that is increasingly designed to benefit everyone except the patient and the person paying the bill.
The story of Dauphin County is being repeated in thousands of jurisdictions across the country. It is a story of good intentions meeting a broken market. As Justin Douglas discovered, the math of modern health care simply doesn’t add up for local governments anymore. When the cost of keeping a workforce healthy becomes the very thing that threatens the financial health of the community they serve, the system has failed. The year 2027 will likely be the year this failure becomes impossible to ignore, forcing a national conversation on whether the "vise" of rising costs can be loosened before it permanently alters the landscape of public service in America.
